AI assistant
Citadel Group Major Shareholding Notification 2022
10454_mrq_2022-12-07_fcc4ae37-4c91-4a50-a0a5-5839faf87ce6.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9439I
Citadel Group
07 December 2022
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Citadel Group |
| Company dealt in | HORIZON THERAPEUTICS PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | Common Stock ISIN IE00BQPVQZ61 |
| Date of dealing | 06 December, 2022 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
| Long | Short | |
| ISIN IE00BQPVQZ61 | Number (%) | Number (%) |
| (1) Relevant securities | 2,769,598 (1.22%) | 188,439 (0.08%) |
| (2) Derivatives (other than options) | 0 (0.00%) | 0 (0.00%) |
| (3) Options and agreements to purchase/sell | 335,501 (0.14%) | 154,920 (0.06%) |
| Total | 3,105,099 (1.36%) | 343,359 (0.15%) |
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale ISIN IE00BQPVQZ61 |
Number of securities | Price per unit (Note 5) |
| Buy Transaction | 1,475 | 96.8500 USD |
| Buy Transaction | 10,279 | 97.4837 USD |
| Buy Transaction | 10,206 | 98.1122 USD |
| Buy Transaction | 10,108 | 98.9077 USD |
| Buy Transaction | 10,000 | 98.9565 USD |
| Buy Transaction | 1,489 | 97.6166 USD |
| Buy Transaction | 636 | 96.8500 USD |
| Buy Transaction | 603 | 97.6281 USD |
| Buy Transaction | 214 | 97.6051 USD |
| Buy Transaction | 146 | 97.7700 USD |
| Buy Transaction | 326 | 97.5579 USD |
| Buy Transaction | 18,702 | 96.8500 USD |
| Buy Transaction | 6,225 | 96.8500 USD |
| Buy Transaction | 10,000 | 97.5160 USD |
| Buy Transaction | 7,521 | 97.3530 USD |
| Buy Transaction | 4,000 | 97.5408 USD |
| Buy Transaction | 1,174 | 97.5579 USD |
| Sell Transaction | 316 | 96.9989 USD |
| Sell Transaction | 103 | 97.8156 USD |
| Sell Transaction | 200 | 97.6500 USD |
| Sell Transaction | 500 | 97.9520 USD |
| Sell Transaction | 1,242 | 97.8020 USD |
| Sell Transaction | 326 | 99.1084 USD |
| DVP Transaction | 1,475 | 96.8500 USD |
| DVP Transaction | 2,300 | 96.8500 USD |
| DVP Transaction | 2,500 | 96.8500 USD |
| DVP Transaction | 6,225 | 96.8500 USD |
| DVP Transaction | 18,702 | 96.8500 USD |
| RVP Transaction | 18,702 | 96.8500 USD |
| RVP Transaction | 7,700 | 96.8500 USD |
| RVP Transaction | 2,500 | 96.8500 USD |
| RVP Transaction | 2,300 | 96.8500 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD ISIN IE00BQPVQZ61 |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. |
Expiry date | Option money paid/ received per unit (Note 5) |
| Call Option | Buy Transaction | 1 | 115.0000 DOL.C-USAA | Amer Opt | 17/02/2023 | 6.0000 USD |
| Call Option | Buy Transaction | 1 | 115.0000 DOL.C-USAA | Amer Opt | 17/02/2023 | 4.7400 USD |
| Call Option | Sell Transaction | 2 | 125.0000 DOL.C-USAA | Amer Opt | 17/02/2023 | 2.0000 USD |
| Call Option | Sell Transaction | 2 | 125.0000 DOL.C-USAA | Amer Opt | 17/02/2023 | 1.3700 USD |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated |
| None |
Is a Supplemental Form 8 attached? (Note 9)
NO
| Date of disclosure: | 07 December, 2022 |
| Contact name: | Paula Sharp |
| Telephone number: | 020 7645 9700 |
| If a connected EFM, name of offeree/offeror with which connected | n/a |
| If a connected EFM, state nature of connection (Note 10) | n/a |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ISEUPGAAPUPPGPM